ResMed Q1 2026 Earnings EPS Beats Estimates but Stock Slips C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution ONCY Q3 2025 Earnings Clinical Progress Overshadows WiderThanExpected Loss HTFC Q1 2026 Earnings Narrow EPS Miss Amid Stable Operations ESAB Q1 2026 Earnings EPS Miss Weighs on Sentiment Despite Resilient Operations NAUT Q1 2026 Earnings EPS Beat of 1886 Reflects Cost Discipline Amid PreRevenue Phase